United States (USA)-Molecular Diagnostics Market, Test Volume Forecast & Companies - Industry Analysis

Molecular diagnostics is a rapidly–advancing area of research and medicine, with new technologies and applications being added continuously. Molecular diagnostics is the promising area which can transform disease diagnosis, as diagnosis based on symptoms and use of surrogate markers is replaced by genomic and proteomic analysis. This fundamental shift offers the promise for early disease detection, potentially before symptoms have even occurred.

View Full Report at http://www.marketresearchreports.biz/analysis/197391

United States molecular diagnostic market for 2018 is anticipated to more than double from its current value in 2013. In United States molecular diagnostic market, infectious disease controls the highest market share in 2013.

But in terms of test volume food pathogen testing takes the lead pushing infectious disease at number two position.

Molecular oncology tests have emerged as a significant rapidly growing market segment. In the current medical diagnostics market, molecular diagnostics for cancer testing offers one of the brightest areas for growth and innovation. United States constitutes the largest regional market for blood screening and blood products. Molecular diagnostics is also starting to emerge as an important tool for HLA Testing, Food Pathogen Detection Testing and other disease areas.

Download Detail Report With Complete TOC at http://www.marketresearchreports.biz/sample/sample/197391

In companies market share Hologic Inc., Myriad Genetics and Becton Dickinson together these 3 companies control more than 50% market share for 2013. However Becton Dickinson is expected to lose its market share gradually and Roche is expected to take its place by 2018.

United States Molecular Diagnostics Market & Test Volume – Application Segment Analysis (2010 – 2018)

1. Oncology Testing

• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Others

2. Infectious Diseases

• Virology Testing
• HPV Testing
• HAI Testing
• Critical Care Testing

3. Genetic Testing

4. Blood Screening

5. Food Pathogen Testing

6. Tissue Typing (HLA Testing)

United States Molecular Diagnostics – Company Wise Sales Analysis (2010 – 2018)

1. Roche

2. Abbott

3. Myriad Genetics

4. BioMerieux

5. Qiagen

6. Hologic Inc.

7. Becton Dickinson

8. Siemens

9. Cepheid

10. Others

Browse Our Press Releases by Prnewswire: http://www.prnewswire.com/news/marketresearchreports.biz